3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
6
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
368
Breast
81
Gastrointestinal
79
Thoracic
76
Genitourinary
64
Dermatologic
38
Head & Neck
33
Sarcoma
25
CNS
19
Other solid neoplasm
12
Lymphoid
12
Plasma cell
8
Other hematologic neoplasm
7
Myeloid
7
Endocrine
4
Classical hematology
3
Other
2
NET
1
Conditions
Neuroendocrine Tumors
46
Neoplasms
8
Carcinoid Tumor
7
Neoplasm Metastasis
5
Gastro-enteropancreatic neuroendocrine tumor
5
Pancreatic Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Gastrointestinal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Neuroendocrine
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Serotonin Syndrome
2
Sarcoma
2
Pheochromocytoma
2
Paraganglioma
2
Neuroblastoma
2
Neoplasms by Site
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Cholangiocarcinoma
2
Carcinoma, Islet Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Adrenal Gland Neoplasms
2
von Hippel-Lindau Disease
1
Vipoma
1
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Ovarian Neoplasms
×
NET
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts